[{"id":"aee25c39-e431-4c28-aa25-5f21ea54d750","acronym":"","url":"https://clinicaltrials.gov/study/NCT05942378","created_at":"2023-07-12T15:08:56.192Z","updated_at":"2024-07-02T16:35:43.394Z","phase":"Phase 1","brief_title":"A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05942378","lead_sponsor":"Fudan University","biomarkers":" IL6 • IL2 • IL10","pipe":"","alterations":" ","tags":["IL6 • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AiRuiLi (adebrelimab) • HRXG-K-1939"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 07/01/2023","start_date":" 07/01/2023","primary_txt":" Primary completion: 09/01/2025","primary_completion_date":" 09/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-07-12"}]